Die Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Mann oder Frau
- 18-64 jaar
Study of an investigational compound that is being developed for the treatment of Parkinson’s disease.
For Part E, the study consists of 1 period during which you will stay in our research facility in Groningen for 19 days (18 nights). Finally, there will be a follow-up visit including a pulmonary function test between 4 and 10 days after discharge from the research facility.
Please note: it may happen that the pulmonary function test takes place on a day other than the follow-up visit.
|Group||19 days stay||follow-up|
|E1c||19 feb t/m 8 mrt 2020||16 mrt 2020|
|E2a||1 t/m 19 apr 2020||27 apr 2020|
|E2b||15 apr t/m 3 mei 2020||11 mei 2020|
|E2c||22 apr t/m 10 mei 2020||18 mei 2020|
You can find the exact dates of each group on our website. If the dates do change you will be notified as soon as possible.
You will receive a gross compensation of € 3423 for participation in any of the groups of Part E.
Travelling expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12 and a maximum of €160 (840 kilometers) per return, regardless of the mode of transportation.